InsiderClue
Insiders · Profile

KARABELAS ARGERIS N

Director at REGENXBIO · Director at Bausch Health Companies · Director at ROCKET PHARMACEUTICALS · and 1 more. Filing since 17 Nov 2006. CIK 0001191229

RGNX REGENXBIO Inc. Director · 5 trades BHC Bausch Health Companies Inc. Director · 1 trade RCKT ROCKET PHARMACEUTICALS, INC. Director · 1 trade VNDA Vanda Pharmaceuticals Inc. Director · 19 trades
Company
Date
Role
Action
Shares
Amount
Of holding
RGNX REGENXBIO Inc.
1 Oct 2024
Director
Sold on a plan
10,000
$101.05K
47.0%
RGNX REGENXBIO Inc.
3 Sep 2024
Director
Sold on a plan
10,000
$115.59K
47.0%
RGNX REGENXBIO Inc.
1 Aug 2024
Director
Sold on a plan
10,100
$136.45K
47.2%
RGNX REGENXBIO Inc.
29 Jul 2024
Director
Sold on a plan
11,000
$165.50K
49.4%
RGNX REGENXBIO Inc.
1 Jul 2024
Director
Sold on a plan
10,000
$112.69K
47.0%
BHC Bausch Health Companies Inc.
11 Aug 2016
Director
Bought
4,000
$98.60K
23.9%
RCKT ROCKET PHARMACEUTICALS, INC.
23 Feb 2015
Director
Bought
603,832
$3.62M
36.1%
VNDA Vanda Pharmaceuticals Inc.
12 Mar 2010
Director
Sold, plan not stated
200,000
$2.36M
100%
VNDA Vanda Pharmaceuticals Inc.
15 Dec 2009
Director
Sold, plan not stated
98,924
$1.09M
33.1%
VNDA Vanda Pharmaceuticals Inc.
14 Dec 2009
Director
Sold, plan not stated
130,000
$1.45M
30.3%
VNDA Vanda Pharmaceuticals Inc.
9 Dec 2009
Director
Sold, plan not stated
107,200
$1.24M
20.0%
VNDA Vanda Pharmaceuticals Inc.
8 Dec 2009
Director
Sold, plan not stated
26,376
$298.05K
4.7%
VNDA Vanda Pharmaceuticals Inc.
7 Dec 2009
Director
Sold, plan not stated
100,000
$1.16M
15.1%
VNDA Vanda Pharmaceuticals Inc.
4 Dec 2009
Director
Sold, plan not stated
100,000
$1.17M
13.1%
VNDA Vanda Pharmaceuticals Inc.
13 Oct 2009
Director
Sold, plan not stated
237,500
$3.00M
23.8%
VNDA Vanda Pharmaceuticals Inc.
23 Feb 2007
Director
Sold, plan not stated
384,130
$9.99M
85.7%
VNDA Vanda Pharmaceuticals Inc.
22 Feb 2007
Director
Sold, plan not stated
72,600
$1.95M
45.0%
VNDA Vanda Pharmaceuticals Inc.
21 Feb 2007
Director
Sold, plan not stated
237,000
$6.34M
71.7%
VNDA Vanda Pharmaceuticals Inc.
20 Feb 2007
Director
Sold, plan not stated
200,000
$5.47M
64.8%
VNDA Vanda Pharmaceuticals Inc.
12 Dec 2006
Chairman of the Board
Sold, plan not stated
424,150
$10.68M
77.7%
VNDA Vanda Pharmaceuticals Inc.
11 Dec 2006
Chairman of the Board
Sold, plan not stated
326,325
$8.61M
68.7%
VNDA Vanda Pharmaceuticals Inc.
27 Nov 2006
Chairman of the Board
Sold, plan not stated
300,000
$4.25M
63.9%
VNDA Vanda Pharmaceuticals Inc.
22 Nov 2006
Chairman of the Board
Sold, plan not stated
300,000
$4.24M
61.4%
VNDA Vanda Pharmaceuticals Inc.
21 Nov 2006
Chairman of the Board
Sold, plan not stated
50,000
$727.50K
19.4%
VNDA Vanda Pharmaceuticals Inc.
20 Nov 2006
Chairman of the Board
Sold, plan not stated
50,000
$764.50K
13.9%
VNDA Vanda Pharmaceuticals Inc.
17 Nov 2006
Chairman of the Board
Sold, plan not stated
270,000
$3.85M
46.3%
26 decisions on file.